Corrigendum to “Clinical use and adverse effects of tyrosine kinase inhibitors in patients with chronic mye-loid leukemia: The role of comorbidities” [Leukem. Res. (2026) 108235]
Authors: Selin Kır, Nigar Abdullayeva, Ali Yılmazer et al.
Publication: Leukemia Research
Published: Jul 1, 2026
Source: Crossref